Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether an SSRI, paroxetine, improves social anxiety
symptoms and alcohol use in individuals who drink to cope with social anxiety disorder.
Phase:
Phase 4
Details
Lead Sponsor:
Medical University of South Carolina
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)